by Ket Patel | Jun 14, 2012 | All Videos For Neurology, Neuro-Oncology
The antidepressant duloxetine reduces chronic pain from chemotherapy-induced peripheral neuropathy with fewer side effects than with current therapies, according to results of a phase III, double-blind trial. Among evaluable patients, 59% reported less pain with...
by Ket Patel | Jun 14, 2012 | All Articles For Neurology, Stroke
Oral contraceptives containing low- or very low-dose estradiol raised the risks of thrombotic stroke and myocardial infarction by a factor of 1 to 2 in a large Danish cohort study. The results were published in the June 14 issue of the New England Journal of Medicine....
by Ket Patel | Jun 14, 2012 | All Articles For Psychiatry, Schizophrenia
Many children with oppositional defiant disorder but not autism nevertheless exhibit elevated symptoms of autism spectrum disorder as well as schizophrenia spectrum disorder. Moreover, children rated by mothers or teachers to have characteristics of anger and...
by Ket Patel | Jun 10, 2012 | All Articles For Neurology, Multiple Sclerosis
The risk of developing progressive multifocal leukoencephalopathy from natalizumab therapy appears to be greater than previously thought, being greatest in multiple sclerosis patients with certain risk factors, according to an updated analysis. The analysis provides...
by Ket Patel | Jun 7, 2012 | All Articles For Neurology, Movement Disorders
Dopamine agonist–induced impulse control disorders may be more likely in Parkinson’s disease patients who smoke, drink, or consume caffeine, according to the first prospective cohort study of the problem. “We found a number of interesting things” when the...
